Synedica GLP-3 R 40mg Pen
99.0%
40mg
40 mg Retatrutide triple-incretin pen by Synedica — maximum strength fat-loss research peptide. Refrigerate. For research use only
Technical specifications
Molecular formula
-
Purity
99.0%
Storage
-20°C, dark
CAS Number
2381089-83-2
Molecular weight
4731.33 g/mol
Reconstitution
-
Research applications
- For research use only
Not for human consumption, veterinary, or diagnostic use. Handled by qualified researchers only.
Description
Synedica GLP-3 R 40mg Pen – Advanced Triple-Incretin Research Formula
The Synedica GLP-3 R 40mg Pen contains 40mg of Retatrutide in a convenient prefilled research format. Designed for advanced laboratory investigation, this formulation supports studies examining the combined activity of GLP-1, GIP, and glucagon receptor pathways within metabolic research models. Unlike single-pathway compounds, Retatrutide is studied for its ability to interact with three distinct receptor systems. Therefore, researchers may use it to explore complex signalling processes associated with energy balance, glucose metabolism, appetite-related pathways, and lipid metabolism. This multi-receptor profile makes the Synedica GLP-3 R 40mg Pen suitable for structured experimental work focused on metabolic signalling.Concentration & Quality
- 40mg Retatrutide per prefilled research pen
- Triple-receptor research profile
- Manufactured to Synedica quality standards
- Convenient format for controlled laboratory protocols
Key Research Features
The 40mg format provides researchers with a higher-concentration option for extended experimental programmes. In addition, the prefilled pen design allows convenient handling within controlled laboratory environments. Researchers may examine Retatrutide in studies involving:- GLP-1 receptor signalling
- GIP receptor activity
- Glucagon receptor pathways
- Energy metabolism
- Glucose regulation mechanisms
- Lipid and metabolic signalling


